Chinese english Germany Japanese Korea

5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole

5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole Struktur
154709-18-9
CAS-Nr.
154709-18-9
Englisch Name:
5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole
Synonyma:
Olmesartan Impurity S;Olmesartan Impurity 25;Olmesartan Impurity 82;Olmesartan Medoxomil-10;Olmesartan1 Impurity 37;Olmesartan ester impurity S;Olmesartan Medoxomil Impurity S;Azilsartan medoxomil impurity225;Losartan Hydroxy N2-Trityl Impurity;Candesartan Hydroxy N2-Trityl Impurity
CBNumber:
CB52512012
Summenformel:
C33H26N4O
Molgewicht:
494.59
MOL-Datei:
154709-18-9.mol
Request For Quotation

5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole Eigenschaften

Schmelzpunkt:
163-166°C
Siedepunkt:
724.8±70.0 °C(Predicted)
Dichte
1.17±0.1 g/cm3(Predicted)
storage temp. 
Refrigerator
Löslichkeit
Chloroform (Slightly), Ethyl Acetate (Slightly, Heated)
pka
14.25±0.10(Predicted)
Aggregatzustand
Solid
Farbe
Off-White

Sicherheit

5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White Solid

Verwenden

Intermediate in the preparation of Losartan impurity J.

5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1H-IMidazole-5-carboxylic acid, 4-(1-hydroxy-1-Methylethyl)-2-propyl-1-[[2'-[1-(triphenylMethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]Methyl]-, ethyl ester 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole

5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 61)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Jusheng Technology Co.,Ltd. 		18871490254
linda@hubeijusheng.com CHINA 28180 58
Standardpharm Co. Ltd. 		86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Hangzhou Huarong Pharm Co., Ltd. 		571-86758373 +8613588754946
 sales@huarongpharm.com CHINA 3149 58
Aromsyn Co., Ltd. 		+86-0571-85585865 +8613336024896
 CB@aromsyn.com China 19185 58
LEAPCHEM CO., LTD. 		+86-852-30606658
market18@leapchem.com China 43348 58
ShenZhen H&D Pharmaceutical Technology Co., LTD 		+86-0755-22677845 +86-13627253706
 sale@hdimpurity.com China 3013 58
Amadis Chemical Company Limited 		571-89925085
sales@amadischem.com China 131980 58
Shanghai Payne Pharmaceutical Technology Co.Ltd 		021-58123769 18678586262
 info@paynepharm.com China 1354 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
 jkinfo@jkchemical.com China 96815 76
Chemsky（shanghai）International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50

154709-18-9()Verwandte Suche:

4-Chlormethyl-5-methyl-1,3-dioxol-2-on Chlortriphenylmethan
  • 2'-[1-(TriphenylMethyl)-1H-tetrazol-5-yl]-[1,1'-biphenyl]-4-Methanol
  • 5-[4'-HydroxyMethyl-(1,1'-biphenyl)-2-yl]-2-triphenylMethyltetrazole
  • 5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-1-triphenylmethyltetrazole
  • (2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol
  • Azilsartan medoxomil impurity225
  • Olmesartan Impurity S
  • [1,1'-Biphenyl]-4-methanol, 2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl]-
  • Olmesartan1 Impurity 37
  • Olmesartan Medoxomil-10
  • Olmesartan Medoxomil Impurity S
  • [4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methanol
  • Olmesartan Medoxomil impurity 18/Losartan Hydroxy N2-Trityl Impurity/Irbesartan Hydroxy N2-Trityl Impurity/Candesartan Hydroxy N2-Trityl Impurity/5-[4’-Hydroxymethyl-(1,1’-biphenyl)-2-yl]-2-triphenylmethyltetrazole
  • Olmesartan Impurity 25
  • Losartan Hydroxy N2-Trityl Impurity
  • Candesartan Hydroxy N2-Trityl Impurity
  • Olmesartan ester impurity S
  • Olmesartan Impurity 82
  • (2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol
  • 154709-18-9
  • C33H26N4O
  • Amines, Aromatics, Heterocycles, Intermediates
  • Amines
  • Aromatics
  • Heterocycles
  • Intermediates
Copyright 2019 © ChemicalBook. All rights reserved